1. < Home

disease burden

Benefits of Earlier Apremilast Initiation in Patients with Psoriasis and Limited Skin Involvement: Results from a Real-World Retrospective Study

Armstrong A, Strober B, Gisondi P, Orroth KK, Cordey M, Kent ST, Deignan C, Jardon S, Hernandez RK, Brookhart MA, Stein Gold L. Benefits of[...]

By afschroeder • August 7, 2025
Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms

Merola JF, Mease PJ, Armstrong AW, Strand V, Lehman T, Varga S, Choi JC, Becker B, Zhong Y, Colombo MJ, Thaçi D, Bili A, Gottlieb[...]

By sjmartinez • May 31, 2025
Racial and Ethnic Disparities and the National Burden of COVID-19 on Inpatient Hospitalizations: A Retrospective Study in the United States in the Year 2020

Nguyen A, Buhr RG, Fonarow GC, Hsu JJ, Brown AF, Ziaeian B. Racial and Ethnic Disparities and the National Burden of COVID-19 on Inpatient Hospitalizations:[...]

By sjmartinez • September 25, 2024
Treatment burden and the perspectives of patients with psoriasis using topical treatments: results from a national survey of adults with psoriasis in the United States

Armstrong A, Young M, Seal MS, Higham RC, Greiling T. Treatment burden and the perspectives of patients with psoriasis using topical treatments: results from a[...]

By sjmartinez • August 12, 2024